Letters: The Tribune Editorial Board should give RFK more credit in his campaign against sugar
In reference to the editorial 'As sugar is attacked, Chicago candymaker Ferrara keeps the Nerds coming' (May 27), the Tribune Editorial Board should do more research and also admit some harsh realities concerning sugar consumption. Is the board aware that about 1 in 5 children are classified as obese, some severely so?
Sadly, many parents don't have the heart to deprive their children of something considered by society (and the board) as a 'treat.' But as Health and Human Services Secretary Robert F. Kennedy so accurately pointed out, it is a form of poison and an addictive one at that. Just examine the percentage of people suffering the effects of Type 2 diabetes. That one disease alone accounts for enormous health care costs — costs that the government must absorb when a patient is on Medicare or Medicaid. So, the government indeed has a vested interest in controlling the manufacturing and consumption of sugar.
Ferrara Candy Co. CEO Katie Duffy stated that 'everything we produce is safe to eat.' That does not mean it is 'healthy' to eat! The board states that it has 'long recoiled against Uncle Sam telling Americans what to eat.' And that 'if a food product is safe from a scientific standpoint, the government has no business blocking it from the marketplace.' Again, that ignores the fact that the government shares some of the burden for the cost of medical care for the health disorders caused by sugar consumption. And just to enlighten the board further, pay for the government. So, it costs us all as a whole.
The board further states that 'armed with that information, we believe people are smart enough to make their own decisions without Nanny State intervention.' The board has to be joking. It gives people far more credit than they deserve.
Sugar is being consumed in quantities that most people are not likely aware of. And that is what I think Kennedy is trying to address. I appreciate what he is trying to achieve, and the board should as well.
Keep in mind that a country is only as strong and as healthy as its people. We have an epidemic of obesity in this country. Don't gloss over the facts in the name of some false sense of sovereignty over choice.Health and Human Services Secretary Robert F. Kennedy Jr. is absolutely correct about the American diet. There's too much salt, sugar and bad fat; not enough fiber; and too many additives. The consequences are substantial: obesity, diabetes, heart disease, kidney disease, cancer and more. He is dead wrong about vaccinations, 'dead' not being just an expression: People are going to die, needlessly.
During a measles epidemic in Samoa, Kennedy campaigned against vaccination; too few people were vaccinated, thousands got sick and dozens died. Almost all healthy individuals who get measles completely recover. About 1 in 1,000, however, will have serious complications or die. Great odds in a casino but not for a preventable disease.
In contrast, there have been no reports of the measles vaccine causing death in healthy people, and the incidence of permanent harm is less than 1 in 500,000.
Kennedy's efforts to restrict the messenger RNA-based COVID-19 vaccine is not based on credible evidence of significant harm. Worldwide, at least 5 billion people have received COVID-19 vaccinations, including hundreds of millions of Americans. Many have sore arms, and some, brief flulike illness. Very rarely does serious short-term illness occur. In contrast, more than 1 million Americans have died from COVID-19, and 20 million Americans have been diagnosed with long COVID-19, sometimes with debilitating symptoms. People who have been vaccinated against COVID-19 have dramatically lower rates of hospitalization, death and long COVID-19.
Kennedy proposes a clinical trial against a placebo to test the safety of COVID-19 vaccines. In any clinical trial, when the drug being studied against a placebo is found to be safe and effective, the trial is stopped. The safety and effectiveness of the COVID-19 vaccine has already been proved; there is no need for a trial.
Kennedy's proclamation restricting recommending who should receive the vaccination is medical idiocy. Infants have poorly developed immune systems and are very vulnerable to infections, including COVID-19. If pregnant women are vaccinated, their babies get some protection against COVID-19. Being under 65 is no guarantee against COVID-19 causing hospitalization or death, and the incidence of some forms of long COVID-19 is actually higher in young people.
It is worth noting that Kennedy made these recommendations on his own without input from recognized experts. There is a new COVID-19 variant, and the need for vaccinations is still great. When the Senate confirmed Kennedy, it failed the American people.Michael J. Medley's letter ('What our nation needs,' May 29) regarding President Donald Trump's 'Big Beautiful Bill,' which has been passed by the House, is on point but misses one very important issue. This bill contains a buried provision seeking to limit courts, including the U.S. Supreme Court, from enforcing their rulings or orders.
In short, it states: 'No court of the United States may use appropriated funds to enforce a contempt citation for failure to comply with an injunction or temporary restraining order if no security was given when the injunction or order was issued.' What I have read says that this means the courts cannot enforce decisions unless the plaintiffs have posted a bond. Federal courts do not require plaintiffs to post bonds; therefore, this provision would mean that the courts would not be able to enforce their rulings. And Trump and his administration could proceed to do anything they want to, regardless of whether it is unconstitutional.
When setting up the federal government, our Founding Fathers did not feel any one person should have all the power. Therefore, they set up a government of three equal parts: executive (president), legislative (Congress) and judicial (Supreme Court). Trump has already taken over the legislative aspect — with no pushback from the Republican majority — by overturning many aspects of the government and funding that had previously been put in place by Congress. Now he wants to make judicial rulings unenforceable.
If Trump does that, he will be king. This country was developed as a democracy, and I believe the majority of Americans do not want a king.
Readers should call their senators and demand this bill not be passed with this provision in it. Save our democracy and our Constitution!I'm thrilled National Public Radio has legally challenged the administration's misguided executive order targeting its appropriately sourced federal funds and relationships with local stations. I've grown accustomed to the measured objectivity and factual analysis of the reporting through daily programs such as 'All Things Considered' and 'Morning Edition.'
We financially support NPR's frequent funding drives, the real lifeblood of its operations, not only because its revenues significantly rely on voluntary contributions by listeners, but also due to its prize-winning journalism that opens our eyes to hard-hitting domestic and international news analysis.
The president's bizarre claims that NPR fails to provide 'fair, accurate or unbiased' programming can be summarily rejected by those who actually listen to the variety of viewpoints included. NPR routinely covers important events like it did with the president's speech to a joint session of Congress in March and even presented rare audio of Supreme Court oral arguments about the birthright citizenship case, followed by riveting independent coverage.
Cutting this funding is more than just a violation of free speech. America should refrain from emulating autocratic leaders in other societies that deliberately silence views it does not like.National Public Radio is suing President Donald Trump's administration because it stopped taxpayer funding to the network; NPR contends that curtails its free speech.
What nonsense. NPR remains free to utter what it wants, but the public does not need to pay for it.
NPR can fund itself and say whatever it pleases. Its reflexive lawsuit is frivolous and vexatious without merit.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
2 hours ago
- Forbes
Price Controls On Doctors Are Costing Patients Dearly
Market Manipulation Just like the December 2024 continuing resolution, the current budget reconciliation bill fails to address the problem of Medicare reimbursing physicians at below market rates. Without a fix, the inevitable consequences will be worsening doctor shortages, declining healthcare quality, higher overall healthcare spending, and the accelerated loss of independent practices. Of course, how do we know that Medicare's payments to doctors are below their economic value? To start, Medicare's reimbursement rates have declined relative to both the cost of running a medical practice and inflation. Doctors consistently report that they lose money treating Medicare patients. A survey of doctors found that Medicare's low reimbursement rates (68%) are a primary threat to independent practices. As for inflation, it has grown 34.5% overall since January 2016 while the prices received by doctors have grown less than half as much - just 15.1%. This is not due to demand for healthcare declining – remember the huge number of aging Baby Boomers seeking health care – or a huge surge in the number of qualified doctors serving patients. In fact, the level of doctors serving patients today - 25.4 active physicians per 10,000 residents - is down from 2019 and has fallen back to 2009 levels. The problem is government setting prices at below market levels. And setting prices below market rates cause adverse consequences to our health, such as fewer doctors available to serve patients. This creates serious health risks for patients including longer wait times for appointments, less access to specialty care, shorter doctor visits, larger numbers of medical errors, and more misdiagnoses or missed diagnoses. These risks are more acute for people living in rural areas, who have a higher chance of living in areas deemed 'medical deserts' or regions that lack sufficient access to pharmacies, primary care providers, and hospitals. Medicare's uneconomical reimbursement system is also changing how patient care is delivered. For example, under the current reimbursement system, Medicare compensates hospitals more than independent physician offices for performing the same service. This incentivizes independent practices to merge with hospitals. Consolidating lower-cost physician practices into higher-cost hospital systems is driving up overall healthcare costs for patients and taxpayers and is reducing patient choice. Congress has acknowledged that there are serious consequences from government price controls, enacting legislation to raise provider payments by 2.9% for most of 2024. But these payments went back down on January 1, and the problem continues to plague the healthcare system. Fixing Medicare's flawed reimbursement policy should be a top priority for Congress. The more efficient reform comprehensively addresses Medicare's broader deficiencies by turning Medicare into a cash-based benefit system that funds health savings accounts (HSAs) for seniors. This direct payment option allows beneficiaries to receive their Medicare benefits in the same manner that they receive their Social Security benefits. At current spending levels, Medicare could give each beneficiary $15,150 annually to cover their insurance and healthcare costs. Under this system, patients and physicians, not bureaucrats, would take change and prices would reflect value. Providers would have to compete and would be incentivized to find new and better ways to expand value and reducing costs for patients. Fundamental reforms that establish well-functioning healthcare and health insurance markets will take time. Given this, Congress could act more immediately to index government payments to medical inflation and stop paying different reimbursement rates for the same services depending on where care is delivered. With more people aging, taxpayers will be spending more and more for Medicare and Medicaid. Unless Congress acts soon to stop Medicare's underpayment of physicians, it is patients who will ultimately pay the highest price with less access to doctors and specialists and longer wait times for life-saving care.
New York Post
5 hours ago
- New York Post
Why Ozempic users should be extra careful during heatwaves
Talk about melting the weight off. Summer may be filled with beach days and barbecues, but it can also bring blistering temperatures. This week, millions of Americans — including New Yorkers — are bracing for what forecasters are calling a 'very sweaty' heatwave. People who are on GLP-1s need to be on particularly high alert amidst the high degrees. New Africa – And people who are on weight loss drugs like Ozempic, Wegovy and Mounjaro need to be on particularly high alert amidst the high degrees. That's because these drugs work by suppressing appetite, which means they can wind up curbing thirst as well. This, in turn, can unwittingly lead to dehydration — a dangerous condition that can cause dizziness, headaches, low blood pressure, blurred vision, kidney problems and, in extreme cases, fatal heatstroke. Since eating normally stimulates saliva flow, eating less while on Ozempic can mean less stimulation to the salivary glands, which can in turn lead to dry mouth — another symptom of dehydration left unchecked. And if you've heard about Ozempic teeth, you know some of the most common side effects of GLP-1s pose their own dangers during a heatwave. 'You'll need to be extra careful about hydration during hot weather as these medications often cause nausea, vomiting or diarrhea — all of which can lead to fluid loss,' nutritional therapist Deborah Grayson told The Daily Mail. 'This is particularly important for new users of the weight loss medication, whose bodies are still adjusting.' 'You'll need to be extra careful about hydration during hot weather as these medications often cause nausea, vomiting or diarrhea — all of which can lead to fluid loss,' Grayson said. millaf – To remain vigilant, Grayson recommends the following: Drink plenty of water, even if you don't feel thirsty Put a timer on to remind you to hydrate Avoid alcohol and caffeine Avoid being outdoors during peak heat hours Eat easy-to-digest foods such as those on the BRAT diet In addition to suppressing thirst and potentially inducing vomiting/diarrhea, GLP-1s could mess with your body's ability to regulate body temperature, making it harder to tolerate heat. This is all the more reason to drink lots of water — sprinkle some electrolytes into the mix to stay hydrated longer. Use urine as your barometer — light yellow means you're in the clear, whereas darker colors are a bad sign. And avoid physical exertion, especially outside. It might be excruciatingly hot, but perhaps the heatwave is a good excuse to stay on your Ozempic butt for a bit.
The Hill
12 hours ago
- The Hill
Thanks to imported drugs, America has lost control of its medicine cabinet
America is facing a growing crisis in its medical system — not from a lack of talent or innovation, but from a breakdown in the control, safety and supply of essential medicines. Our growing reliance on imports is now driving serious drug shortages, destabilizing supply chains and increasingly making medications unsafe. At the root of it is a hard truth: We no longer have control of the medicines we depend on every day. In 2002, America manufactured 83.7 percent of the pharmaceuticals it consumed. By 2024, that number had dropped to just 37.1 percent. Meanwhile, the U.S. pharmaceutical trade deficit has soared, reaching a record $118.3 billion in 2024. We didn't just outsource manufacturing — we outsourced the sovereignty and safety of our health care system. This means that nearly two-thirds of America's pharmaceutical supplies are now imported. Most critical medications, such as generic drugs, now come from China and India. China controls 80 to 90 percent of the global supply of active pharmaceutical ingredients — the chemical building blocks of modern medicine. Even drugs labeled 'Made in the USA' often chemically originate in China. And India, which produces about half of America's finished generic drugs, relies on China for up to 80 percent of its active pharmaceutical not a supply chain — it's a ticking time something goes wrong, American patients suffer. In 2023, the Food and Drug Administration shut down a single Indian plant responsible for 50 percent of the U.S. supply of cisplatin, a critical chemotherapy drug, after uncovering a 'cascade of failure' in safety practices and shredded documents soaked in acid. With no domestic backup, patients nationwide had their treatments delayed. That wasn't a fluke. 40 percent of U.S. generic drugs have only one FDA-approved manufacturer. Because of that single chokepoint, when one factory fails, the whole system can crack. We are now seeing widespread drug shortages across the medical system. Hospital pharmacists report an average of 301 critical drug shortages at any given time. And 85 percent say these shortages are moderately or critically affecting care. Doctors often lack crucial medicines such as antibiotics, sedatives and cancer drugs. These aren't obscure drugs. They're foundational medicines. But America no longer makes them. Even when imported drugs do arrive, they're not always safe. A 2025 study found that Indian generics are 54 percent more likely to cause serious side effects than their U.S.-made counterparts. Indian factory violations have also been tied to at least eight U.S. patient deaths. China's record is equally disturbing. In 2008, dozens of Americans died after receiving contaminated heparin from Chinese suppliers. This isn't what the American people want. In a national survey, 85 percent of hospital pharmacists said they would pay more for safer generics. But under today's rules, price overshadows quality. Hospitals have little oversight of drug quality — and foreign producers face few consequences for cutting corners. Even the federal government is flying blind. A 2023 Department of Defense review found that 22 percent of essential military-use drugs had unknown ingredient sourcing. That's a national security April, the Trump administration took a necessary step by launching an investigation into generic pharmaceutical imports that correctly frames the issue as a national security threat. But that recognition alone isn't enough. To address this crisis, Washington should impose targeted tariffs on generic drugs from adversarial nations. It must also rebuild domestic pharmaceutical production through tax credits and long-term contracts. America urgently needs full transparency in drug labeling to disclose where drugs and their ingredients are made. The FDA must step up — with stronger enforcement abroad and a ban on imports from repeat safety violators. And to secure critical ingredients during market disruptions, Washington must pursue a long-term vision that includes a 'strategic pharmaceutical reserve.' This isn't just protectionism. It's a restoration of America's medical security. No nation can call itself sovereign if it can't produce its own medicines, and no patient is safe if their health care depends on quality control in a factory 8,000 miles decades, we were told that offshoring production would make things cheaper, smoother and more efficient. But America can no longer depend on unstable foreign suppliers. It's time to restore our pharmaceutical independence and take back control of our medicine cabinet. Andrew Rechenberg is an economist at the Coalition for a Prosperous America.
